4th Quarter - Amendment

PODESTA GROUP, INC. for EMD SERONO INC

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 21, 2009 $50,000 Replaced
4th Quarter - Amendment (this page) Jan 22, 2010 $50,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions Comparative Effectiveness 2008 Medicare Bill H.R. 1424, Emergency Economic Stabilization Act of 2008

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
SHARON COHEN —
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4 (110th), S. 3 (110th), S. 2029 (110th), S. 2662 (110th), H.R. 2606 (110th), H.R. 3162 (110th), H.R. 5480 (110th), S. 1376 (110th), H.R. 1424 (110th)

Budget/Appropriations BUD

LHHS Appropriations Drug importation House Concurrent Resolution 312 House Budget Resolution Senate Concurrent Resolution 70 Senate Budget Resolution Comparative Effectiveness

LobbyistCovered position, as disclosed
SHARON COHEN —
RANDALL GERARD —
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Patent & Trademark Office (PTO); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Pharmacy PHA

S. 877, Controlling the Abuse of Prescriptions Act of 2007 Drug importation H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
ANDREW KAUDERS Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 1956 (110th), S. 1505 (110th), S. 877 (110th), S. 1695 (110th), H.R. 5629 (110th), S. 2029 (110th), S. 623 (110th), H.R. 1038 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008 H. R. 1908, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
SHARON COHEN —
COURTNEY HAGEN —
CLAUDIA JAMES —
ANTHONY PODESTA —
NICOLE C YOUNG New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Executive Office of the President (EOP)

Bills named: S. 1145 (110th), S. 3600 (110th), H.R. 1908 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
MERCK SERONO S.A. Germany Germany 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.